PHAT
PHAT
NASDAQ · Pharmaceuticals

Phathom Pharmaceuticals Inc

$5.25
+0.17 (+3.35%)
As of Nov 7, 1:54 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 15 83%
Hold 3 17%
Sell 0 0%
Price Target
Analyst Price Target +866.5% upside
Low Target $34.41
Average Target $50.74
High Target $70.04
Current Price $5.25
Current
$5.25
Target
$50.74
$34.41 $50.74 avg $70.04
Scenario Analysis
Bear Case
$34.41
555.4%
Low target
Base Case
$50.74
+866.5%
Avg target
Bull Case
$70.04
+1,234.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$18.31
-71.3% from high
52-Week Low
$5.02
+4.7% from low
Target vs 52W High
$50.74
+177.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%